Erratum: Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells (RNA. (2014) 20:4 (474–482) DOI: 10.1261/rna.041376.113);Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells

RNA

Volumn 20, Issue 4, 2014, Pages 474-482

  Goncalves, Vânia ^a,b   Henriques, Andreia ^a,b   Pereira, Joana ^a,b   Costa, Ana Neves ^c   Moyer, Mary Pat ^d   Moita, Luís Ferreira ^c   Gama Carvalho, Margarida ^b,e   Matos, Paulo ^a,b   Jordan, Peter ^a,b  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

^c INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^d INCELL Corporation ^*  (United States)

^e UNIVERSITY OF LISBON   (Portugal)

Author keywords

Alternative splicing; Colorectal cancer; Signal transduction pathways; SRPK1; SRSF1

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA PRECURSOR; PROTEIN AKT3; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE B BETA; PROTEIN RAC1B; PROTEIN SRPK1; PROTEIN SRSF1; RAC1 PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CANCER CELL; COLORECTAL CANCER; ENZYME ACTIVITY; ENZYME INHIBITION; MOUSE; NONHUMAN; NUCLEAR IMPORT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; COLORECTAL CANCER; SIGNAL TRANSDUCTION PATHWAYS; SRPK1; SRSF1;

ALTERNATIVE SPLICING; BLOTTING, WESTERN; CELL NUCLEUS; COLORECTAL NEOPLASMS; EXONS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MICROSCOPY, FLUORESCENCE; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RAC1 GTP-BINDING PROTEIN; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 84896522562     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.079955.123     Document Type: Erratum

References (68)

1. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. 1997. β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J 16: 3797-3804.
2. Amin EM, Oltean S, Hua J, Gammons MVR, Hamdollah-Zadeh M, Welsh GI, Cheung M-K, Ni L, Kase S, Rennel ES, et al. 2011. WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. Cancer Cell 20: 768-780.
3. Barros P, Jordan P, Matos P. 2009. Rac1 signaling modulates BCL-6- mediated repression of gene transcription. Mol Cell Biol 29: 4156-4166.
4. Blaustein M, Pelisch F, Coso OA, Bissell MJ, Kornblihtt AR, Srebrow A. 2004. Mammary epithelial-mesenchymal interaction regulates fibronectin alternative splicing via phosphatidylinositol 3-kinase. J Biol Chem 279: 21029-21037.
5. Blaustein M, Pelisch F, Tanos T, Munoz MJ, Wengier D, Quadrana L, Sanford JR, Muschietti JP, Kornblihtt AR, Cáceres JF, et al. 2005. Concerted regulation of nuclear and cytoplasmic activities of SR proteins by AKT. Nat Struct Mol Biol 12: 1037-1044.
6. Blaustein M, Pelisch F, Srebrow A. 2007. Signals, pathways and splicing regulation. Int J Biochem Cell Biol 39: 2031-2048.
7. Blencowe BJ. 2012. An exon-centric perspective. Biochem Cell Biol 90: 603-612.
8. Buljan M, Chalancon G, Eustermann S, Wagner GP, Fuxreiter M, Bateman A, Babu MM. 2012. Tissue-specific splicing of disordered segments that embed binding motifs rewires protein interaction networks. Mol Cell 46: 871-883.
9. Cáceres JF, Misteli T, Screaton GR, Spector DL, Krainer AR. 1997. Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity. J Cell Biol 138: 225-238.
10. Calarco JA, Zhen M, Blencowe BJ. 2011. Networking in a global world: Establishing functional connections between neural splicing regulators and their target transcripts. RNA 17: 775-791.
11. David CJ, Manley JL. 2010. Alternative pre-mRNA splicing regulation in cancer: Pathways and programs unhinged. Genes Dev 24: 2343-2364.
12. Ellis JD, Barrios-Rodiles M, Colak R, Irimia M, Kim T, Calarco JA, Wang X, Pan Q, O'Hanlon D, Kim PM, et al. 2012. Tissue-specific alternative splicing remodels protein-protein interaction networks. Mol Cell 46: 884-892.
13. Eperon IC, Makarova OV, Mayeda A, Munroe SH, Cáceres JF, Hayward DG, Krainer AR. 2000. Selection of alternative 5' splice sites: Role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1. Mol Cell Biol 20: 8303-8318.
14. Esufali S, Charames GS, Bapat B. 2007. Suppression of nuclear Wnt signaling leads to stabilization of Rac1 isoforms. FEBS Lett 581: 4850-4856.
15. Fiegen D, Haeusler LC, Blumenstein L, Herbrand U, Dvorsky R, Vetter IR, Ahmadian MR. 2004. Alternative splicing of Rac1 generates Rac1b, a self-activating GTPase. J Biol Chem 279: 4743-4749.
16. Fukuhara T, Hosoya T, Shimizu S, Sumi K, Oshiro T, Yoshinaka Y, Suzuki M, Yamamoto N, Herzenberg LA, Herzenberg LA, et al. 2006. Utilization of host SR protein kinases and RNA-splicing machinery during viral replication. Proc Natl Acad Sci 103: 11329-11333.
17. Ghigna C, Moroni M, Porta C, Riva S, Biamonti G. 1998. Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Res 58: 5818-5824.
18. Ghosh G, Adams JA. 2011. Phosphorylation mechanism and structure of serine-arginine protein kinases. FEBS J 278: 587-597.
19. Gon?alves V, Matos P, Jordan P. 2008. The β-catenin/TCF4 pathway modifies alternative splicing through modulation of SRp20 expression. RNA 14: 2538-2549.
20. Gonçalves V, Matos P, Jordan P. 2009. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3- kinase and Wnt pathways. Hum Mol Genet 18: 3696-3707.
21. Hayes GM, Carrigan PE, Miller LJ. 2007. Serine-arginine protein kinase 1 overexpression is associated with tumorigenic imbalance in mitogen- activated protein kinase pathways in breast, colonic, and pancreatic carcinomas. Cancer Res 67: 2072-2080.
22. Hernández F, Pérez M, Lucas JJ, Mata AM, Bhat R, Avila J. 2004. Glycogen synthase kinase-3 plays a crucial role in t exon 10 splicing and intranuclear distribution of SC35. Implications for Alzheimer's disease. J Biol Chem 279: 3801-3806.
23. Heyd F, Lynch KW. 2010. Phosphorylation-dependent regulation of PSF by GSK3 controls CD45 alternative splicing. Mol Cell 40: 126-137.
24. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A. 1998. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3β and β-catenin and promotes GSK-3β-dependent phosphorylation of β-catenin. EMBO J 17: 1371-1384.
25. Jiang K, Patel NA, Watson JE, Apostolatos H, Kleiman E, Hanson O, Hagiwara M, Cooper DR. 2009. Akt2 regulation of Cdc2-like kinases (Clk/Sty), serine/arginine-rich (SR) protein phosphorylation, and insulin-induced alternative splicing of PKCβII messenger ribonucleic acid. Endocrinology 150: 2087-2097.
26. Jordan P, Brazao R, Boavida MG, Gespach C, Chastre E. 1999. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene 18: 6835-6839.
27. Karni R, de Stanchina E, Lowe SW, Sinha R, Mu D, Krainer AR. 2007. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol 14: 185-193.
28. Liu L, Xie N, Rennie P, Challis JRG, Gleave M, Lye SJ, Dong X. 2011. Consensus PP1 binding motifs regulate transcriptional corepression and alternative RNA splicing activities of the steroid receptor coregulators, p54nrb and PSF. Mol Endocrinol 25: 1197-1210.
29. Liu J, Lee W, Jiang Z, Chen Z, Jhunjhunwala S, Haverty PM, Gnad F, Guan Y, Gilbert HN, Stinson J, et al. 2012. Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events. Genome Res 22: 2315-2327.
30. Lu Y, Muller M, Smith D, Dutta B, Komurov K, Iadevaia S, Ruths D, Tseng JT, Yu S, Yu Q, et al. 2011. Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling. Oncogene 30: 4567-4577.
31. Matos P, Jordan P. 2006. Rac1, but not Rac1B, stimulates RelB-mediated gene transcription in colorectal cancer cells. J Biol Chem 281: 13724-13732.
32. Matos P, Jordan P. 2008. Increased Rac1b expression sustains colorectal tumor cell survival. Mol Cancer Res 6: 1178-1184.
33. Matos P, Collard JG, Jordan P. 2003. Tumor-related alternatively spliced Rac1b is not regulated by Rho-GDP dissociation inhibitors and exhibits selective downstream signaling. J Biol Chem 278: 50442-50448.
34. Matos P, Oliveira C, Velho S, Gonçalves V, da Costa LT, Moyer MP, Seruca R, Jordan P. 2008. B-RafV600E cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival. Gastroenterology 135: 899-906.
35. Matter N, Herrlich P, König H. 2002. Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature 420: 691-695.
36. Moita CF, Chora A, Hacohen N, Moita LF. 2012. RNAi screen for kinases and phosphatases that play a role in antigen presentation by dendritic cells. Eur J Immunol 42: 1843-1849.
37. Moura-Alves P, Neves-Costa A, Raquel H, Pacheco TR, D'Almeida B, Rodrigues R, Cadima-Couto I, Chora ?, Oliveira M, Gama- Carvalho M, et al. 2011. An shRNA-based screen of splicing regulators identifies SFRS3 as a negative regulator of IL-1β secretion. PLoS One 6: E19829.
38. Moyer MP, Manzano LA, Merriman RL, Stauffer JS, Tanzer LR. 1996. NCM460, a normal human colon mucosal epithelial cell line. In Vitro Cell Dev Biol Anim 32: 315-317.
39. Ngo JCK, Chakrabarti S, Ding J-H, Velazquez-Dones A, Nolen B, Aubol BE, Adams JA, Fu X-D, Ghosh G. 2005. Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2. Mol Cell 20: 77-89.
40. Nowak DG, Amin EM, Rennel ES, Hoareau-Aveilla C, Gammons M, Damodoran G, Hagiwara M, Harper SJ, Woolard J, Ladomery MR, et al. 2010. Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: A novel therapeutic strategy for angiogenesis. J Biol Chem 285: 5532-5540.
41. Pagani F, Baralle FE. 2004. Genomic variants in exons and introns: Identifying the splicing spoilers. Nat Rev Genet 5: 389-396.
42. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. 2008. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40: 1413-1415.
43. Patel NA, Kaneko S, Apostolatos HS, Bae SS, Watson JE, Davidowitz K, Chappell DS, Birnbaum MJ, Cheng JQ, Cooper DR. 2005. Molecular and genetic studies imply Akt-mediated signaling promotes protein kinase CβII alternative splicing via phosphorylation of serine/arginine- rich splicing factor SRp40. J Biol Chem 280: 14302-14309.
44. Pelisch F, Khauv D, Risso G, Stallings-Mann M, Blaustein M, Quadrana L, Radisky DC, Srebrow A. 2012. Involvement of hnRNP A1 in the matrix metalloprotease-3-dependent regulation of Rac1 premRNA splicing. J Cell Biochem 113: 2319-2329.
45. Plasencia C, Martínez-Balibrea E, Martinez-Cardús A, Quinn DI, Abad A, Neamati N. 2006. Expression analysis of genes involved in oxaliplatin response and development of oxaliplatin-resistant HT29 colon cancer cells. Int J Oncol 29: 225-235.
46. Qian W, Liang H, Shi J, Jin N, Grundke-Iqbal I, Iqbal K, Gong C-X, Liu F. 2011. Regulation of the alternative splicing of t exon 10 by SC35 and Dyrk1A. Nucleic Acids Res 39: 6161-6171.
47. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, et al. 2005. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436: 123-127.
48. Sanford JR, Ellis JD, Cazalla D, Cáceres JF. 2005. Reversible phosphorylation differentially affects nuclear and cytoplasmic functions of splicing factor 2/alternative splicing factor. Proc Natl Acad Sci 102: 15042-15047.
49. Schnelzer A, Prechtel D, Knaus U, Dehne K, Gerhard M, Graeff H, Harbeck N, Schmitt M, Lengyel E. 2000. Rac1 in human breast cancer: Overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 19: 3013-3020.
50. Shin C, Manley JL. 2004. Cell signalling and the control of pre-mRNA splicing. Nat Rev Mol Cell Biol 5: 727-738.
51. Silva AL, Carmo F, Bugalho MJ. 2013. RAC1b overexpression in papillary thyroid carcinoma: A role to unravel. Eur J Endocrinol 168: 795-804.
52. Singh R, Valcárcel J. 2005. Building specificity with nonspecific RNAbinding proteins. Nat Struct Mol Biol 12: 645-653.
53. Smith CW, Valcárcel J. 2000. Alternative pre-mRNA splicing: The logic of combinatorial control. Trends Biochem Sci 25: 381-388.
54. Srebrow A, Kornblihtt AR. 2006. The connection between splicing and cancer. J Cell Sci 119: 2635-2641.
55. Stallings-Mann ML, Waldmann J, Zhang Y, Miller E, Gauthier ML, Visscher DW, Downey GP, Radisky ES, Fields AP, Radisky DC. 2012. Matrix metalloproteinase induction of Rac1b, a key effector of lung cancer progression. Sci Transl Med 4: 142ra95.
56. Stamm S. 2008. Regulation of alternative splicing by reversible protein phosphorylation. J Biol Chem 283: 1223-1227.
57. Stickeler E, Kittrell F, Medina D, Berget SM. 1999. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 18: 3574-3582.
58. Van der Houven van Oordt W, Diaz-Meco MT, Lozano J, Krainer AR, Moscat J, Cáceres JF. 2000. The MKK3/6-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation. J Cell Biol 149: 307-316.
59. Venables JP. 2006. Unbalanced alternative splicing and its significance in cancer. Bioessays 28: 378-386.
60. Visvikis O, Lorès P, Boyer L, Chardin P, Lemichez E, Gacon G. 2008. Activated Rac1, but not the tumorigenic variant Rac1b, is ubiquitinated on Lys 147 through a JNK-regulated process. FEBS J 275: 386-396.
61. Wang Z, Burge CB. 2008. Splicing regulation: From a parts list of regulatory elements to an integrated splicing code. RNA 14: 802-813.
62. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB. 2008. Alternative isoform regulation in human tissue transcriptomes. Nature 456: 470-476.
63. Weg-Remers S, Ponta H, Herrlich P, König H. 2001. Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway. EMBO J 20: 4194-4203.
64. Xiao SH, Manley JL. 1997. Phosphorylation of the ASF/SF2 RS domain affects both protein-protein and protein-RNA interactions and is necessary for splicing. Genes Dev 11: 334-344.
65. Xie J, Lee J-A, Kress TL, Mowry KL, Black DL. 2003. Protein kinase A phosphorylation modulates transport of the polypyrimidine tractbinding protein. Proc Natl Acad Sci 100: 8776-8781.
66. Zhong X-Y, Ding J-H, Adams JA, Ghosh G, Fu X-D. 2009. Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones. Genes Dev 23: 482-495.
67. Zhou Z, Qiu J, Liu W, Zhou Y, Plocinik RM, Li H, Hu Q, Ghosh G, Adams JA, Rosenfeld MG, et al. 2012. The Akt-SRPK-SR axis constitutes a major pathway in transducing EGF signaling to regulate alternative splicing in the nucleus. Mol Cell 47: 422-433.
68. Zhou C, Licciulli S, Avila JL, Cho M, Troutman S, Jiang P, Kossenkov AV, Showe LC, Liu Q, Vachani A, et al. 2013. The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis. Oncogene 32: 903-909.